Some experts suggest that anti-obesity pharmacotherapy, including GLP-1 RAs, should become a primary treatment goal for individuals with diabetes, especially in the early stages
elevated pulse rate linked to glucagon receptor activation requires monitoring
Interventions aimed at blocking collagen and hyaluronan production, such as a neutralizing antibody against TGF- [127], the angiotensin inhibitor losartan [128,129,130,131], or the antifibrotic drugs tranilast and pirfenidone [132,133,134] have shown promising results in alleviating solid stress and increasing breast tumor blood supply and drug delivery
However, it should be cautioned that this is an evolving area of research, and whether supplementing with additional protein or other ingredients can offset the effects of the GLP-1 is unknown